Drug & intervention
24 HR bupropion hydrobromide 174 MG Extended Release Oral Tablet [Aplenzin]
RxCUI 993552
What this record represents
SBD · RxNormThis is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
AplenzinBN · CureCurrent ID 40900
bupropion hydrobromide 174 MG [Aplenzin]SBDC · CureCurrent ID 46551
bupropion hydrobromide 348 MG [Aplenzin]SBDC · CureCurrent ID 46559
bupropion hydrobromide 522 MG [Aplenzin]SBDC · CureCurrent ID 46563
bupropion Extended Release Oral Tablet [Aplenzin]SBDF · CureCurrent ID 40901
24 HR bupropion hydrobromide 348 MG Extended Release Oral Tablet [Aplenzin]SBD · CureCurrent ID 46560
24 HR bupropion hydrobromide 522 MG Extended Release Oral Tablet [Aplenzin]SBD · CureCurrent ID 46564
Advertisement
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.